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Protein-Losing 
Enteropathy 
Congenital heart defects requiring single 
ventricle palliation are a rare but life-
threatening occurrence.  There are 
multiple defects resulting in single 
ventricle physiology including defects in 
which the right or left ventricle within the 
heart is either undeveloped (hypoplastic 
left heart syndrome, hypoplastic right 
heart syndrome), or the valve to the main 
pulmonary artery did not form (pulmonary 
atresia).  These defects prevent the heart 
from supplying adequate blood flow to the 
lungs or body. Single ventricle congenital 
heart defects are not easily treated 
surgically due to their complexity in 
nature.  Single ventricle surgical  palliation 
typically involves three open-heart 
surgeries including the Norwood  or 
Hybrid Procedure, the Bidirectional Glenn 
procedure, and finally the Fontan 
procedure, (Hardiman, 2013, p. 327).   
 
Nursing implications for protein-losing 
enteropathy are multi-faceted.  The nurse 
should provide emotional support for the 
patient and their family.  PLE is typically a 
chronic, fatal condition so the diagnosis 
can be devastating.  The nurse can improve 
the experience for the patient and family 
by advocating for early palliative care 
involvement.   There are several ethical 
issues revolving around the care of the 
single ventricle population, “…Because the 
neonate is incapable of participating in the 
decision-making process, the nurse must 
advocate for the child adequately and 
succinctly explaining all facets of each of 
the available treatment options to the 
parents,” (Zeigler, 2003, p. 69). The nurse 
is responsible for the proper 
administration of prescribed therapies and 
educating the patient and/or their families 
on their use.  The patient should be closely 
monitored for worsening symptoms, 
specifically respiratory failure related to 
ascites or pleural effusions.  The nurse 
should be prepared to intervene in a 
medical emergency such as cardiac 
tamponade from a pericardial effusion. . 
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Nursing Implications 
The pathophysiology of the development of protein-losing enteropathy has not been 
precisely determined but several theories exist.  The lymphatic and cardiovascular system are 
closely related; elevated central venous pressures increases lymphatic production while 
simultaneously slowing lymphatic return (Meadows & Jenkins, 2011, p. 373). One theory is 
that the increased systemic venous pressures related to the passive blood flow to the 
pulmonary artery causes dilation of the lymphatic system within the gastrointestinal tract 
leading to leakage of protein into the gastrointestinal system (Umar & DiBaise, 2009).  A 
second theory is the elevated systemic venous pressure alongside the impaired cardiac 
output from a single ventricle state combine to impair perfusion and oxygenation to the 
gastrointestinal system (Umar & DiBaise, 2009).  The impaired blood flow and ischemia 
compromises the epithelium and leads to protein leaking into the lumen. “Gross and 
microscopic pathologic examination of the intestine in patients with protein-losing 
enteropathy demonstrates several characteristic findings consistent with lymphatic 
engorgement, stasis and insufficiency,” (Meadows & Jenkins, 2011, p. 369).  A third theory 
suggests that the chronic low cardiac output state of a person with single ventricle circulation 
causes inflammation; cytokines cause vasoconstriction and have been found at elevated 
levels immediately after Fontan palliation which is not surprising, but a study in 2006 found 
elevated cytokine levels years after the procedure (Ostrow, Freeze, & Rychik, 2006, p. 698). 
The pathophysiologic significance of these findings lies in the fact that there is no definitive 
causative source leading to the development of protein-losing enteropathy.  The lack of a 
determined underlying cause creates difficulty for providers attempting to medically manage 
this population. 
Theories on the Pathophysiology behind 
Protein-Losing Enteropathy 
The loss of protein into the gastrointestinal tract creates many life-altering and life-
threatening clinical manifestations.  Patients with PLE can become severely edematous which 
can inhibit respiration.  Diarrhea may occur causing electrolyte imbalances as well as 
dehydration.  Ascites develops as the leaking of protein continues; it can eventually become 
severe enough to cause discomfort and difficulty breathing, requiring abdominal paracentesis.  
Pleural effusions are a common occurrence in patients with PLE, requiring the placement of 
chest tubes or even chemical or surgical pleurodesis.   Pericardial effusions can also occur 
which have the potential to become life-threatening (Caltepe & Comba, 2013).  
Clinical Manisfestations of Protein-Losing 
Enteropathy 
 
The Norwood procedure is the traditional 
operation performed during the neonatal 
period.  This procedure converts the single 
operating ventricle into the main pumping 
chamber for both systemic and pulmonary 
blood flow.  The pulmonary artery and aorta 
are combined, removing the main pulmonary 
artery from the branching pulmonary 
arteries.  A shunt is placed between the neo-
aorta and the pulmonary arteries to provide 
blood flow to the lungs, (Hardiman, 2013, p. 
327).   
 
Nationwide Children’s Hospital in Columbus, 
Ohio, often performs the Galantowicz-
Cheetham Procedure, also known as the 
Hybrid procedure, in place of the Norwood 
procedure.  This procedure entails bands 
being placed around the pulmonary arteries 
to reduce pulmonary blood flow which 
encourages shunting back into the systemic 
system. A stent is then placed in the patent 
ductus arteriosus to maintain mixed 
oxygenated and deoxygenated blood being 
delivered to the body.  Finally, a balloon atrial 
septostomy is performed to allow for more 
mixing of oxygenated and deoxygenated 
blood.This procedure requires less 
manipulation of the heart than the Norwood 
procedure and also allows the child to avoid 
cardiopulmonary bypass (Rowland, et al., 
2008.) 
 
The Bi-directional Glenn is performed four to 
six months after the Norwood procedure.  
The shunt between the pulmonary artery and 
the aorta is removed.  The superior vena cava 
is then connected directly to the right 
pulmonary artery.  This connection brings 
deoxygenated blood from the upper half of 
the body passively to the lungs, bypassing the 
right ventricle. (Hardiman, 2013, p. 327).   
 
The Fontan operation is typically 
performed18-24 months after the bi-
directional Glenn procedure.  The inferior 
vena cava is connected to the right 
pulmonary artery.  This, combined with the 
bi-directional Glenn, allows for all 
deoxygenated blood to flow passively to the 
lungs. The single ventricle is now only 
providing systemic perfusion (Hardiman, 
2013, p. 328).    
 
Figure 1. Hypoplastic Left Heart Syndrome 
anatomy (left). Norwood procedure anatomy 
(right). 
Figure 3. Bidirectional Glenn anatomy (left). 
Intracardiac fontan anatomy (middle).  
Extracardiac fontan anatomy (right). 
Protein-losing enteropathy (PLE) is a 
rare but serious condition that can occur 
following Fontan palliation. This disease 
occurs when protein from the body is 
“lost” or leaking into the intestinal tract.  
Hypoalbuminemia in generally the first 
indication of PLE (Sathiyasekaran, 2013).  
Diagnosis is then confirmed by the 
presence of fecal alpha 1-antitrypsin, 
proving the existence of blood protein 
below the pylorus in the gastrointestinal 
tract (Braampskamp, Dolman, & 
Tabbers, 2010).   
 
PLE is said to occur in approximately 3–
15% of patients after the Fontan 
operation and carries a high risk of 
mortality (Umar & DuBaise, 2009).  Five 
and ten year survival rates after PLE 
diagnosis following the Fontan surgery 
were noted to be 48% and 30% 
respectively (Umar & DuBaise, 2009).  
 
 
 
 
Risk Factors for 
Developing PLE 
Pre-operative risk factors indicated 
include having a hypoplastic left 
ventricle and increased end-diastolic 
pressures.  Longer operative times have 
been indicated in the development of 
PLE post-operatively.  Post-operative 
echocardiograms showing a reduced 
ventricular area have been linked with 
the development of PLE (Umar & 
DuBaise, 2009).  Post-operative renal 
failure is also related to the 
development of PLE in the future 
(Meadows & Jenkins, 2011, p. 370).  
 
Figure 4. Depiction of the development of protein-losing enteropathy 
related to lymphatic and venous obstruction. 
Management of protein-losing enteropathy 
has proven to be inadequate for patients and 
frustrating for healthcare professionals.  
Supportive measures include dietary 
modifications (high protein, low fat), diuretics 
including Lasix and spironolactone, and 
intermittent albumin infusions (Braamskamp, 
Dolman, & Tabbers, 2009, p. 1183).   
 
More specific treatment includes heparin 
therapy which has shown limited success 
(Meadows & Jenkins, 2011, p. 371).  Heparin’s 
mechanism of action in aiding in the resolution 
of PLE is unclear.  A deficiency of enterocyte 
heparin in patients that showed success with 
heparin therapy has been suggested 
(Meadows & Jenkins, 2011, p. 371).   
Corticosteroids have been used as well with 
some limited success with 2-3 weeks of 
treatment, the mechanism of action in the 
disease remains unclear but is thought to be 
related to its anti-inflammatory effects 
(Meadows & Jenkins, 2011, p. 371).  Adrenal 
suppression has been commonly found among 
patients with PLE, often requiring stress-doses 
of corticosteroids (Goldberg, Dodds, & Rychik, 
2011, p. 79).  
 
Surgical treatments include cardiac 
catheterization to relieve any obstructions to 
systemic or pulmonary blood flow.  Creating a 
fenestration within the Fontan when systemic 
pressures are elevated to allow blood flow 
into the right atrium has shown some 
encouraging results; the creation of a 
fenestrated Fontan increased the patient’s risk 
for stroke (Meadows & Jenkins, 2011, p. 371). 
Attempting to improve the low cardiac state 
that is unavoidable with single ventricle 
circulation via atrioventricular pacing when 
appropriate has shown some success at 
improving levels of serum protein (Goldberg, 
Dodds, & Rychik, 2010, p. 116). Cardiac 
transplantation is viewed as the final option 
for patients with unrelenting protein-losing 
enteropathy.  Following cardiac 
transplantation, recurrence of PLE has been 
rare (Meadows & Jenkins, 2011, p. 372).  
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